Drug intelligence / Profile preview

autologous burn-derived stem cells

Development stage
Unknown
Lead developer
Sunnybrook Health Sciences Centre
Modality
Stem Cell Therapies → Cell Therapies
Administration
Topical
01

Overview

Autologous burn-derived stem cells are progenitor cells harvested from the discarded or damaged skin tissue of burn patients. These cells are isolated from the viable portions of burn wounds and have been shown to retain stem cell characteristics, including the ability to differentiate and promote tissue repair. In clinical applications, these cells are seeded onto a dermal regeneration template, such as Integra® (a bilayer matrix of bovine collagen and glycosaminoglycan), to create a bioengineered skin substitute known as Integra-SC. The therapeutic objective is to enhance the wound healing response, improve the quality of the resulting scar, and reduce the overall formation of hypertrophic scars in patients with severe burn injuries by utilizing the patient's own regenerative cellular material.

Other names
Integra-Stem Cellscellularized Integraburn-derived stem cells

Beyond the preview

Go deeper on autologous burn-derived stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous burn-derived stem cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call